[Influence of the anti-inflammatory agent No. 533 methopyrimazole on renal function in chronic kidney patients].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002712:Chlorides / Q000378:metabolism; D002908:Chronic Disease; D005260:Female; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D006400:Hematocrit; D006801:Humans; D007668:Kidney / Q000098:blood supply; D007677:Kidney Function Tests; D008297:Male; D010953:Plasma Volume; D011188:Potassium / Q000378:metabolism; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D002712:Chlorides; D011720:Pyrazoles; D011743:Pyrimidines; D012964:Sodium; D011188:Potassium
Der Einfluss des Antiphlogisticum Nr. 553 Methopyrimazol auf die Nierenfunktion von Chronisch Nierenkranken.